Late Gadolinium Enhancement (LGE) is an advanced imaging modality harnessed in cardiovascular magnetic resonance imaging (MRI) for the detailed examination of heart tissue. The technique relies on the unique properties of gadolinium-based contrast agents, allowing for the enhanced visualization of fibrotic or scarred regions within the myocardium. This method proves particularly useful in unraveling the intricacies of myocardial infarctions, inflammatory cardiomyopathies, and an array of cardiac conditions. By strategically timing image acquisition after the administration of gadolinium-based contrast agents, LGE facilitates the identification of areas exhibiting delayed contrast uptake. This temporal approach enables clinicians to precisely locate and assess pathological changes within the heart muscle. Notably, LGE offers a non-invasive means of delving into the structural abnormalities of the myocardium, contributing significantly to the diagnostic armamentarium of cardiology.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States